Pharmaceutical Drug Targets and Diseases
From Proteopedia
(Difference between revisions)
| Line 83: | Line 83: | ||
**Metabolic Disorders | **Metabolic Disorders | ||
***[[Acid-beta-glucosidase]] | ***[[Acid-beta-glucosidase]] | ||
| + | ***[[Molecular_Playground/Human_PPCA|Protective Protein/Cathepsin A (PPCA)]] | ||
| + | ***[[Molecular_Playground/Human_Protective_Protein_Cathepsin_A|Protective Protein/Cathepsin A (PPCA)]] | ||
***[[Treatment_of_Gaucher_disease]] | ***[[Treatment_of_Gaucher_disease]] | ||
| + | |||
**Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | **Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders | ||
Revision as of 10:27, 24 September 2010
The following is a list of major pharmaceutical compound targets, organized by disease.
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Alexander Berchansky, Eran Hodis, Thomas J. Stout, Wayne Decatur
